INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30

INTELLIGENT BIO SOLUTIONS INC.

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K/A on Oct 21, 2026

$1.53+0.03 (+2.00%)

Close on Oct 19, 2026

Community

Notes and questions about Intelligent Bio Solutions from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Intelligent Bio Solutions's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Feb 12, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is INBS.

Revenue growth38.1% · median 17.6%

Gross margin48.6% · median 60.9%

Operating margin-299.1% · median -847.4%

Net margin-294.9% · median -735.8%

Advertisement
300 × 250